NCT04497987 A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and Staff Status COMPLETED Phase PHASE3
NCT04493502 A Study of LY3041658 in Adults With Hidradenitis Suppurativa Status COMPLETED Phase PHASE2
NCT04486352 A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT04484779 A Study of an Insulin Management System in Participants With Type 1 or Type 2 Diabetes Status COMPLETED Phase NA
NCT04481113 Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer Status COMPLETED Phase PHASE1
NCT04476108 Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Diabetic Peripheral Neuropathic Pain Status COMPLETED Phase PHASE2
NCT04469764 Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer Status RECRUITING Phase PHASE2
NCT04469062 A Study of Mirikizumab (LY3074828) in Participants With Ulcerative Colitis Status WITHDRAWN Phase PHASE3
NCT04456686 Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Osteoarthritis Status COMPLETED Phase PHASE2
NCT04451408 A Study of LY3372993 in Participants With Alzheimer's Disease (AD) and Healthy Participants Status COMPLETED Phase PHASE1
NCT04450394 A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT04437511 A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04433585 A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE) Status COMPLETED Phase PHASE2
NCT04427501 A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness Status COMPLETED Phase PHASE2/PHASE3